FDA requests additional information on a formulation component - HUNTSVILLE, AL, Nov. 03, 2025 (GLOBE NEWSWIRE) -- (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing ...
Amazon S3 on MSN
Marketing firms are developing technology to influence dreams
Dream hacking technology can alter or control dreams, with potential applications in therapy, education, and creativity, but ...
Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for serious and rare diseases, today ...
Alvotech (ALVO) said Monday that the U.S. Food and Drug Administration issued a complete response letter for its biologics ...
The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.
The FDA’s platform technology designation program is intended to provide efficiencies in drug development, manufacturing, and review processes for drug product applications that incorporate designated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback